Archive for November 2020
In Silico Performance of a Rapid Sepsis Test in Patients with Candidemia
SeptiCyte® RAPID differentiated patients with candidemia from those with INSI/SIRS, not infected and healthy subjects
Read MoreComparison of a Cartridge-Based Host Gene Expressions Test to a Manual Method for Use in the Diagnosis of Sepsis
SeptiCyte® RAPID test is a rapid, repeatable, reproducible, near-patient, immune-response sepsis diagnostic, providing accurate results in ~ 1 hr to differentiate sepsis from SIRS
Read MoreImmunexpress to Present SeptiCyte® RAPID Data at the Association for Molecular Pathology Annual Meeting
Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced further SeptiCyte® RAPID data demonstrating performance, reproducibility and identification of fungal infections, in two poster presentations at the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo on Nov. 16-20. “Our SeptiCyte® technology leverages host-response gene-expression biomarkers…
Read MoreImmunexpress to Present SeptiCyte® RAPID Data at the Association for Molecular Pathology Annual Meeting
Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that it will present data in two posters and host a workshop at the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo taking place virtually on Nov. 16-20, 2020. Details of the presentations are as follows:…
Read MoreSCCM Podcast: Severe COVID-19 and Sepsis
Severe COVID-19 infection can be a form of viral sepsis with occasionally concomitant bacterial infection. Pamela M. Peeke MD, MPH, FACP, FACSM, is joined by Russell Miller, MD, MPH, FCCM, to discuss the definition of sepsis and overlap with case descriptions of patients with severe COVID-19, how experience with viral sepsis can be leveraged to…
Read More